bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: O S A J J M A M F J
2013: D N O

 
  Other news for:
Infection
Meningitis
 Resources from HONselect
2 Vaccines Help Cut Bacteria That Cause Meningitis, Study Finds
Shot could reduce risk that people who carry germs will spread them to others, research suggests

By Robert Preidt

TUESDAY, Aug. 19, 2014 (HealthDay News) -- Two new vaccines can reduce the spread of meningitis by reducing the number of meningitis-causing bacteria that people carry, according to a new study.

Researchers tested the two vaccines -- MenACWY-CRM and 4CMenB -- on volunteers aged 18 to 24. MenACWY-CRM cut meningitis-causing bacteria populations in the nose and throat by 39 percent and 4CMenB lowered those populations by 20 to 30 percent.

The findings, published online Aug. 19 in The Lancet, could change the way that new vaccines are made in the future, according to study leader Dr. Robert Read, professor of infectious diseases at the University of Southampton in the United Kingdom.

"The standard practice is to vaccinate with the aim of inducing high levels of antibodies in the blood to protect against the disease, but we know that these antibodies can disappear over the course of a few months," Read said in a university news release.

"This study is telling us that the vaccines also have an effect on carriage in the throat and explains why they can be so effective across the population," he added.

Meningitis is an infection of the membrane that surrounds the brain and spinal cord. Meningitis-causing bacteria are common and carried harmlessly in the nose and throat of about 10 percent of people. The bacteria can be passed from person to person through close contact. Anyone can develop meningitis, but infants and young children are at greatest risk, according to background information in the news release.

"This is a significant piece of work in helping more and more people be protected from meningitis. We have shown that vaccines modify the way the bacteria are carried, so even when the antibodies are no longer present in the blood, the carriage in the throat is still prevented, and so is onward transmission of the infection to others," Read explained.

"This could provide a degree of herd protection against meningitis if implemented in a campaign in which high transmission occurs, for example in teenagers and young adults," he noted.

More information

The U.S. National Library of Medicine has more about meningitis.

SOURCE: University of Southampton, news release, Aug. 18, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=690896

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Meningitis
Infection
Blood
Nose
Risk
Adult
Brain
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact